[HOTAIR] Here’s a horror show of a story that you’re probably not going to see on CNN anytime soon. A report emerged on Thursday indicating that the puberty-blocking drug Leuprolide Acetate (Lupron) has resulted in tens of thousands of serious "adverse reactions" in patients, including more than six thousand deaths. That’s bad enough, but it’s even more significant when you consider that this is one of the drugs being administered by doctors to so-called "transgender children" to unnaturally prevent their normal sexual development. And the testing done on the drug by the FDA for such applications appears to be thin at best. More than 6,300 adults have died from reactions to a drug that is used as a puberty blocker in gender-confused children, Food & Drug Administration data reportedly shows.
"Between 2012 and June 30 of this year, the FDA documented over 40,764 adverse reactions suffered by patients who took Leuprolide Acetate (Lupron), which is used as a hormone blocker. More than 25,500 reactions logged from 2014-2019 were considered ’serious,’ including 6,370 deaths," The Christian Post reported on Thursday.
"Lupron is being prescribed off-label for use in children who have been diagnosed with gender dysphoria despite the lack of formal FDA approval for that purpose," the outlet explained.
| g(r)omgoru submitted the same story, commenting: |
Related:
CNN: 2019-09-26 Mitt Romney adviser sits on Burisma board of directors
CNN: 2019-09-26 Bomb attack on police bus in southern Turkey injures 5
CNN: 2019-09-26 Cool Video: Helicoptering to the Himalayas
CNN: 2019-09-26 Mitt Romney adviser sits on Burisma board of directors
CNN: 2019-09-26 Bomb attack on police bus in southern Turkey injures 5
CNN: 2019-09-26 Cool Video: Helicoptering to the Himalayas
Related:
FDA: 2019-09-24 More blood pressure medicines recalled over possible cancer-causing impurity
FDA: 2019-09-04 ‘Servant Class' that Serves the Rich Among Fastest Growing U.S. Workforces
FDA: 2019-08-10 FBI Can't Unlock Dayton Shooter's Phone
FDA: 2019-09-24 More blood pressure medicines recalled over possible cancer-causing impurity
FDA: 2019-09-04 ‘Servant Class' that Serves the Rich Among Fastest Growing U.S. Workforces
FDA: 2019-08-10 FBI Can't Unlock Dayton Shooter's Phone
Related:
Gender dysphoria: 2019-09-22 A California Court Dealt a Blow to Religious Liberty
Gender dysphoria: 2019-09-19 John Hopkins Psychiatrist: ‘Gender Confusions Are Mostly Driven by Psychological and Psychosocial Problems’
Gender dysphoria: 2019-08-30 Idaho Governor Criticizes 'Activist Court' for Ordering Gender Surgery for Convicted Child Molester
Gender dysphoria: 2019-09-22 A California Court Dealt a Blow to Religious Liberty
Gender dysphoria: 2019-09-19 John Hopkins Psychiatrist: ‘Gender Confusions Are Mostly Driven by Psychological and Psychosocial Problems’
Gender dysphoria: 2019-08-30 Idaho Governor Criticizes 'Activist Court' for Ordering Gender Surgery for Convicted Child Molester